Kenvue is expected to announce its third-quarter results by early November, and analysts expect a notable decline in earnings ...

For over a decade, and as recently as August, FDA has fully evaluated the emerging scientific evidence and repeatedly ...

“For over a decade — and as recently as August — FDA has fully evaluated the emerging scientific evidence and repeatedly ...

Starboard Value CEO Jeff Smith said that he is "thrilled to own" Kenvue (NYSE:KVUE) even though the stock is down ~30% year ...

After popular pain med Tylenol came under fire from officials in the Trump administration for an alleged link to autism if ...

Kenvue urged U.S. regulators to deny a request warning against Tylenol’s use during pregnancy, laying out the most detailed ...

A potential legal headache for consumer healthcare giant Kenvue ( KVUE 8.36%) was causing pain for investors on Thursday.

Explore Kenvue Inc. (NYSE:KVUE) trends, dividends, and market activity among consumer stocks in S&P 500 today.

On Oct. 17, Kenvue filed a response to the Citizen Petition, arguing against the need to add a pregnancy/autism risk warning ...

I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.

Kenvue has urged U.S. regulators to reject a request seeking autism warning label on its popular over-the-counter pain ...

Kenvue, Tylenol manufacturer, has asked US regulators to reject a request for an autism warning label on Tylenol when used ...